Can a gentler iron pill break the anemia cycle in IBD?

NCT ID NCT07739368

Completed Disease control Sponsor: Jiangsu Aosaikang Pharmaceutical Co., Ltd. Source: ClinicalTrials.gov ↗

First seen Jul 31, 2026 · Last updated Jul 31, 2026

Summary

This trial tests whether ferric maltol, an oral iron supplement, can safely raise hemoglobin levels in adults with inflammatory bowel disease (IBD) who have iron deficiency anemia and have not responded to or cannot tolerate standard ferrous iron pills. Participants take either ferric maltol or a placebo twice daily for 12 weeks. The main goal is to see if hemoglobin improves more with ferric maltol than with placebo.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Ferric maltol capsules (an oral iron supplement)
What this could lead to: If effective, this could offer a well-tolerated oral option to treat iron deficiency anemia in people with inflammatory bowel disease who cannot use standard iron pills.
What could go wrong: The trial is relatively small and early-stage, so results may not hold in larger groups. Ferric maltol can still cause gastrointestinal side effects, and its benefit over placebo is not yet proven.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INFLAMMATORY BOWEL DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

inflammatory bowel disease iron deficiency anemia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

IRON DEFICIENCY ANAEMIA

Contacts and locations

Locations

Jiangsu Aosaikang Pharm

Nanjing, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.